Mirati - oncology?

Quote
Meeks announces plan to acquire Feregene AND Kala - combined firm will have single $2 stock listing under symbol “DSTR” and will rebrand as DumpstrFire Therapeutics. Meeks to be Chair and CEO
 




anonymous said:
That was an easy prediction. Look at the short bus riders you have running some of your field team departments. Many have run several of their previous employers into they ground.

You guys needed to take more finance classes and drink less Kool-Aid before you joined a overhyped turd. I guess that big equity enticement in a huge stock option number now look like a bust since they are $100 underwater.

Amgen will literally wipe this company off the map before long.
Click to expand...
 




Yeah Baby! Those short sales just brought me $283,000.00 in profits. I just knew your leadership team would make it happen. It was a semi-risk but considering the leadership I wasn’t that concerned, and I’m not even talking about Meek. Bet paid off well. Thanks Mirati for making it happen. Daddy gets a new boat.
 




























So Mirati will have peak sale of what $72 million ? Maybe $81 million per year ? So valuation if closer to $240 Million - today’s market cap over $2 Billion. Jeez that’s making the shorts tons of bucks as this baby crashes and burns. Meeks for Chump of the Year
 




anonymous said:
So Mirati will have peak sale of what $72 million ? Maybe $81 million per year ? So valuation if closer to $240 Million - today’s market cap over $2 Billion. Jeez that’s making the shorts tons of bucks as this baby crashes and burns. Meeks for Chump of the Year
Click to expand...

What’s surprising? He paid over $1 billion for an asset when he was at Ipsen that’ll be lucky to do $50 million a year.
 




















Even worse for the people who joined early who will get the raw end of the stick when it comes to stock and options vs. those who get hired on later when their strike is under 40.
 




anonymous said:
Game over.

ASCO: It's all tied up? Mirati's KRAS data are 'identical' to Amgen's, researcher says
Click to expand...

So "equal efficacy" at the studied dose...yet Spira says the tox is due to the high dose...so do we really think if we lower...er I mean 'optimize' the dose to solve for the tox concerns the efficacy will stay the same? We are screwed, because really aren't patients and oncologists always looking for a new drug with similar efficacy with greater toxicity!!!

We tried, it didn't work out. It happens. Time to move on.
 












The goal is like 90 bec trying to be like pharma but the rumor is they arent bringing in 2nd wave as planned will be biotech sized. This after the unblinded the hires to each other Rookie mistake the cco should be fired

anonymous said:
Even worse for the people who joined early who will get the raw end of the stick when it comes to stock and options vs. those who get hired on later when their strike is under 40.
Click to expand...
 




Top Bottom
Back
Quote